Organization · Venture Capital
No Label Ventures
No Label Ventures is a London-based venture capital firm that invests in pre-seed and seed-stage startups across Europe, focusing on companies with immigrant founders. The firm aims to support these entrepreneurs by providing early-stage funding and resources.
Overview
What No Label Ventures does
What No Label Ventures is
No Label Ventures is a London-based venture capital firm that invests in pre-seed and seed-stage startups across Europe, focusing on companies with immigrant founders. The firm aims to support these entrepreneurs by providing early-stage funding and resources.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2022
- Approximate age
- About 4 years
- Structured capabilities
- Funder
- Last reviewed
- May 4, 2026
Official channels
Find No Label Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
No Label Ventures as a funder
Investment thesis
No Label Ventures believes that immigration fosters unique entrepreneurial advantages, enabling immigrant founders to generate disproportionate startup returns. The fund aims to identify and enhance the potential of these founders before the broader market recognizes their value.
Focus narrative
No Label Ventures invests in early-stage startups, typically providing funding between $150,000 and $250,000 per round. The organization often acts as the first investor, engaging with founders who may still be employed or in the process of developing a minimum viable product (MVP). Their focus is on immigrant founders, recognizing the unique advantages they bring to the entrepreneurial landscape.
Value beyond capital
No Label Ventures adds value to its portfolio companies by introducing founders to a network of angels, downstream VCs, and corporate clients, including private equity-owned enterprises. Additionally, the fund provides support with visa and immigration processes, helping immigrant founders navigate challenges unique to their status.
Terms and economics
- Typical check
- $150,000–$250,000
Focus and fit
- Stages
- Pre-seed · Seed
- Regions
- EuropeUnited Kingdom
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 17
Portfolio context
Notable portfolio companies include: 11x: GTM digital workers for AI-powered sales automation. Callyope: Technology for brain health monitoring. Guided Energy: Automation solutions for transportation software. Intropy: Industrial software automation solutions. Melotech: AI-generated musical artists and songs. Mesh: A network for crypto payments. Mizou: A platform for roleplay-based training. Nozomio: Agents for software development. Pangea Bio: Nature-inspired drug discovery. PostX: Logistics powered by electric vehicles. Spore Bio: Instant microbe testing technology. Uncovr: Automation for surgical documentation and billing. Vega: Alternatives asset operating system. Zango: Automation for financial compliance.
Common questions
What to know about No Label Ventures
Upseed classifies No Label Ventures under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 4, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.